BRITTANY KESTER: Open Payments
NPI 1265989446 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 28 payments from 14 companies in 2025. Trend: 2023 $915 · 2024 $755 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $83 |
| GlaxoSmithKline, LLC. | 5 | $81 |
| ViiV Healthcare Company | 3 | $61 |
| Lilly USA, LLC | 3 | $48 |
| Novo Nordisk Inc | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| Organon LLC | 3 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| SI-BONE, INC. | 1 | $20 |
Products named: NURTEC ODT, APRETUDE, MOUNJARO, Veozah, TRELEGY ELLIPTA, SHINGRIX, NEXPLANON, ZAVZPRET.
Industry payments across UT — which companies pay providers there.
